SEC Company Response from Catheter Precision, Inc. (VTAK) (CIK 0001716621) (VJET) — May 19, 2020
Catheter Precision, Inc. (VTAK) (CIK 0001716621)
Date: May 19, 2020 · CIK: 0001716621 · Accession: 0001564590-20-026137
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-237701
Letter
rmed-corresp.htm
May 19, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Mail Stop 3030
Washington, DC 20549-3720
Attention:
Courtney Lindsay
Ada Sarmento
Re:
Ra Medical Systems, Inc.
Registration Statement on Form S-1
File No. 333-237701
Acceleration Request
Requested Date: May 20, 2020
Requested Time: 9:00 A.M. Eastern Daylight Time,
or as soon thereafter as practicable
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Ra Medical Systems, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-1 (File No. 333-237701) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Michael Nordtvedt at (206) 883-2524.
[Signature page follows]
* * * *
Securities and Exchange Commission
May 19, 2020
Page 2
Sincerely,
RA MEDICAL SYSTEMS, INC.
Show Raw Text
CORRESP 1 filename1.htm rmed-corresp.htm May 19, 2020 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Mail Stop 3030 Washington, DC 20549-3720 Attention: Courtney Lindsay Ada Sarmento Re: Ra Medical Systems, Inc. Registration Statement on Form S-1 File No. 333-237701 Acceleration Request Requested Date: May 20, 2020 Requested Time: 9:00 A.M. Eastern Daylight Time, or as soon thereafter as practicable Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Ra Medical Systems, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-1 (File No. 333-237701) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Michael Nordtvedt at (206) 883-2524. [Signature page follows] * * * * Securities and Exchange Commission May 19, 2020 Page 2 Sincerely, RA MEDICAL SYSTEMS, INC. /s/ Andrew Jackson Andrew Jackson Chief Financial Officer cc: Jonathan Will McGuire, Ra Medical Systems, Inc. Daniel Horwood, Ra Medical Systems, Inc. Martin J. Waters, Wilson Sonsini Goodrich & Rosati P.C. Michael Nordtvedt, Wilson Sonsini Goodrich & Rosati, P.C.